MedTrace Logo

Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic

NCT04443764 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 287

Last updated 2020-06-23

No results posted yet for this study

Summary

Migrants and refugees are vulnerable subgroups in general with regards to symptoms of psychopathology. Furthermore, recent calls for paper urge investigation on current mental health status of migrants and refugees during the pandemic, as different barriers such as lack of emotional support from relatives, in addition to language barriers potentially impairing comprehension about the pandemic having the chance to increase symptoms of psychopathology such as anxiety and depression. This study seeks to investigate the levels of mental health symptoms (i.e., depression, general anxiety, and health anxiety) among immigrants and refugees in Norway during the COVID-19 pandemic. Demographic factors will be investigated to identify subgroups with increased risk of meeting clinically significant depression and anxiety symptoms, as established by validated cut-offs to be elaborated below. Furthermore, transdiagnostic predictors which may prove as useful intervention targets will be investigated.

Conditions

Sponsors & Collaborators

  • Modum Bad

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Sverre Urnes Johnson, PhD · University of Oslo & Modum Bad

  • KariAnne Vrabel, PhD · Modum Bad

  • Omid Ebrahimi, Mr · University of Oslo & Modum Bad

  • Asle Hoffart, PhD · Modum Bad & University of Oslo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2020-07-13
Completion
2020-07-13

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443764 on ClinicalTrials.gov